• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGenmab A/S
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    DKK1,702.000.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    • Market Cap
      DKK101.26bn
    • Enterprise Value
      DKK126.40bn
    • Revenue
      $3.72bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GMAB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GMAB Dividends
    All News

    NASDAQ RESUMED AT 01:50 PM

    Picture of Genmab A/S logoGenmab A/S
    16/01/2026 18:50
    NASDAQ RESUMED  GMAB.O  AT 01:50 PM
    

    Recent news on Genmab A/S

    See all news
    • Brief: Genmab Says Orbis Investment Management Holds 4.99% Of Genmab Voting Rights As Of June 12

      15/06/2026 17:05
    • Brief: Genmab Announces Epcoritamab Monotherapy And Epcoritamab-Based Combination Regimens Demonstrate High Response Rates In Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

      13/06/2026 17:46
    • Brief: Genmab Presents Epcore Fl-1 Data Showing Consistent Efficacy, Safety For Epcoritamab Combination

      11/06/2026 15:48
    • Brief: Genmab Says Orbis Investment Management Limited Holds 5.08% Of Genmab A/S As Of May 8, 2026

      08/05/2026 20:09
    • Genmab falls after 'uneventful' Q1, profit miss

      08/05/2026 12:02

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.